Showing results (511-520 of 523) with videos related to
Sort By:
Pageof 53
Biodesign Research|October 18, 2023
Plant Biosystems Design Research Roadmap 1.0Xiaohan Yang, June I Medford, Kasey Markel, et al.Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.Nature Communications|December 16, 2021
Critical Assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflowsTim Van Den Bossche, Benoit J Kunath, Kay Schallert, et al.Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.NPJ Breast Cancer|February 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancerRita A Mukhtar, Soumya Gottipati, Christina Yau, et al.The Lancet. Oncology|December 13, 2021
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patientsChristina Yau, Marie Osdoit, Marieke van der Noordaa, et al.Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.Nature Communications|December 3, 2017
The Kalanchoë genome provides insights into convergent evolution and building blocks of crassulacean acid metabolismXiaohan Yang, Rongbin Hu, Hengfu Yin, et al.NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.Pageof 53